Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases

Scandinavian Journal of Rheumatology

Volumn 32, Issue 4, 2003, Pages 247-252

  Okada, Jun ^a   Hamana, T ^a   Kondo, H ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti U1RNP antibody; Aseptic meningitis; MCTD; NSAIDs; SLE

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; COTRIMOXAZOLE; ETODOLAC; IBUPROFEN; IMMUNOGLOBULIN; LOXOPROFEN; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; RIBONUCLEOPROTEIN ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN; SULINDAC;

ADOLESCENT; ADULT; ARTICLE; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HOSPITAL; HUMAN; IMMUNOPATHOLOGY; MALE; MEDICAL RECORD; MIXED CONNECTIVE TISSUE DISEASE; PATIENT SELECTION; POLYMYOSITIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE; MENINGITIS, ASEPTIC; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 0142120651     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310003767     Document Type: Article

References (15)

1. Canoso JJ, Cohen AS. Aseptic meningitis in systemic lupus erythematosus. Report of three cases. Arthritis Rheum 1975;18:369-74.
2. Ruggieri AP. Neuropsychiatric lupus: nomenclature, classification, criteria, and other confusional states. Arthritis Rheum 2001;45:406-9.
3. West SG. Systemic lupus erythematosus and nervous system. In: Wallace DJ, Hahn BH editors. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams & Wilkins; 2002: 694-738.
4. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159:1185-94.
5. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Safety 2000;22: 215-26.
6. Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. J Am Med Assoc 1978; 239:1062-4.
7. Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med 1975;58:644-54.
8. Bennett RM, Bong DM, Spargo BH. Neuropsychiatric problems in mixed connective tissue disease. Am J Med 1978;65:955-62.
9. Hoffman M, Gray RG. Ibuprofen-induced meningitis in mixed connective tissue disease. Clin Rheumatol 1982;1:128-30.
10. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Vitali C, Moutsopoulos HM, Bombardieri S. [The European Community Study Group on diagnostic criteria for Sjögren's syndrome.] Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis 1994;53:637-47.
14. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980;23:341-3.
15. Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shiokawa Y et al. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985;12:919-23.